Recognition and Management of Significant Drug Interactions in HIV Patients – Challenges in Using Available Data to Guide Therapy

por Pau, Alice K., Boyd, Sarita D.
Publicado 2010

Antiretroviral Therapy: Current Drugs

por Pau, Alice K., George, Jomy M.
Publicado 2014

Impaired Maraviroc and Raltegravir Clearance in a Human Immunodeficiency Virus–Infected Patient with End-Stage Liver Disease and Renal Impairment: A Management Dilemma

por Pau, Alice K., Penzak, Scott R., Boyd, Sarita D., McLaughlin, Mary, Morse, Caryn G.
Publicado en Pharmacotherapy (2012)

Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Updated Guidelines From the Centers for Disease Control and Prevention, National Instit...

por Masur, Henry, Brooks, John T., Benson, Constance A., Holmes, King K., Pau, Alice K., Kaplan, Jonathan E.
Publicado 2014

373. Immune Reconstitution Inflammatory Syndrome in Patients with HIV/AIDS and Histoplasmosis: A Case Series

por Boulougoura, Afroditi, Laidlaw, Elizabeth, Roby, Gregg, Mejia, Yolanda, Pau, Alice, Sheikh, Virginia, Sereti, Irini, Manion, Maura
Publicado en Open Forum Infect Dis (2019)

Lack of Effect from a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Efavirenz or Lopinavir-ritonavi...

por Dlamini, Judith N., Hu, Zonghui, Somaroo, Harsha, Highbarger, Helene C., Follmann, Dean A., Dewar, Robin L., Pau, Alice K.
Publicado 2011

Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient

por Boyd, Sarita D., Maldarelli, Frank, Sereti, Irini, Ouedraogo, G. Laissa, Rehm, Catherine A., Boltz, Valerie, Shoemaker, Diana, Pau, Alice K.
Publicado 2011

Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects

por Calderón, Mónica M., Penzak, Scott R., Pau, Alice K., Kumar, Parag, McManus, Maryellen, Alfaro, Raul M., Kovacs, Joseph A.
Publicado en Clin Infect Dis (2016)

Plasma Pharmacokinetics of Sulfadiazine Administered Twice Daily versus Four Times Daily Are Similar in Human Immunodeficiency Virus-Infected Patients

por Jordan, M. Kelli, Burstein, Aaron H., Rock-Kress, Diane, Alfaro, Raul M., Pau, Alice K., Kovacs, Joseph A., Piscitelli, Stephen C.
Publicado 2004

Iatrogenic Cushing’s Syndrome Following Epidural Triamcinolone in an HIV-1 Infected Patient Undergoing Therapy with Ritonavir-Lopinavir

por Ramanathan, Roshan, Pau, Alice K., Busse, Kristin H., Zemskova, Marina, Nieman, Lynnette, Kwan, Richard, Hammer, Jean H., Mican, JoAnn M., Maldarelli, Frank
Publicado 2008

Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19

por Kuriakose, Safia, Singh, Kanal, Pau, Alice K., Daar, Eric, Gandhi, Rajesh, Tebas, Pablo, Evans, Laura, Gulick, Roy M., Lane, H. Clifford, Masur, Henry
Publicado en Ann Intern Med (2021)

Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients

por Grant, Philip M., Sheikh, Virginia, DerSimonian, Rebecca, Rupert, Adam, Roby, Gregg, Pau, Alice, Sneller, Michael C., Rico, Sheryl-vi, Brown, Todd T., Sereti, Irini
Publicado en AIDS Res Hum Retroviruses (2015)

Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia Cohort

por George, Jomy M, Kuriakose, Safia S, Monroe, Anne, Hou, Qingjiang, Byrne, Morgan, Pau, Alice K, Masur, Henry, Hadigan, Colleen, Castel, Amanda D, Horberg, Michael A
Publicado en Clin Infect Dis (2020)

D-dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS

por Porter, Brian O., Ouedraogo, G. Laissa, Hodge, Jessica, Smith, Margo, Pau, Alice, Roby, Gregg, Kwan, Richard, Bishop, Rachel, Rehm, Catherine, Mican, JoAnn, Sereti, Irini
Publicado 2010

Decreased absorption of dolutegravir and tenofovir disoproxil fumarate, but not emtricitabine, in an HIV-infected patient following oral and jejunostomy-tube administration

por Brooks, Kristina M., Garrett, Katy L., Kuriakose, Safia S., George, Jomy M., Balba, Gayle, Bailey, Bria, Anderson, Megan, Lane, H. Clifford, Maldarelli, Frank, Pau, Alice K.
Publicado en Pharmacotherapy (2017)

Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir

por George, Jomy M, Kuriakose, Safia S, Dee, Nicola, Stoll, Pam, Lalani, Tahaniyat, Dewar, Robin, Khan, Muhammad A, Rehman, Muhammad T, Grossman, Zehava, Maldarelli, Frank, Pau, Alice K
Publicado en Open Forum Infect Dis (2018)

Eight-day Inpatient Directly Observed Therapy for Antiretroviral Therapy (ART) Failure: A Tool For Preventing Unnecessary ART Changes and Optimizing Adherence Support

por Winchester, Nicole E, Maldarelli, Frank, Mejia, Yolanda, Dee, Nicola, Dewar, Robin, Laidlaw, Elizabeth, Kuriakose, Safia S, Stoll, Pamela, Proschan, Michael, Lane, H Clifford, Pau, Alice K
Publicado en Clin Infect Dis (2020)

Influence of Low-dose Ritonavir With and Without Darunavir on the Pharmacokinetics and Pharmacodynamics of Inhaled Beclomethasone

por BOYD, Sarita D., HADIGAN, Colleen, MCMANUS, Maryellen, CHAIREZ, Cheryl, NIEMAN, Lynnette K., PAU, Alice K., ALFARO, Raul M., KOVACS, Joseph A., CALDERON, Monica M., PENZAK, Scott R.
Publicado 2013

Defective HIV-1 proviruses produce viral proteins

por Imamichi, Hiromi, Smith, Mindy, Adelsberger, Joseph W., Izumi, Taisuke, Scrimieri, Francesca, Sherman, Brad T., Rehm, Catherine A., Imamichi, Tomozumi, Pau, Alice, Catalfamo, Marta, Fauci, Anthony S., Lane, H. Clifford
Publicado en Proc Natl Acad Sci U S A (2020)

Genotypic Resistance at Viral Rebound among Patients Who Received Lopinavir/ritonavir- or Efavirenz-Based First Antiretroviral Therapy in South Africa

por Dlamini, J. Nomthandazo, Hu, Zonghui, Ledwaba, Johanna, Morris, Lynn, Maldarelli, Frank M., Dewar, Robin L., Highbarger, Helene C., Somaroo, Harsha, Sangweni, Phumelele, Follmann, Dean A., Pau, Alice K.
Publicado 2011